The IgG subclasses of platelet‐associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura
Abstract:Summary. The majority of patients with idiopathic thrombocytopenic purpura (ITP) have antiplatelet autoantibodies that are most frequently directed against platelet glycoproteins IIb/IIIa or Ib/IX/V. However, there is some debate whether the immune response is oligoclonal or polyclonal in nature. We investigated the subclass distribution of anti-IIb/IIIa IgG autoantibodies in 59 prospectively studied patients with ITP. We also tested patients with a variety of thrombocytopenic disorders (n ¼ 31) and healthy co… Show more
“…Patients with ITP have anti-PLT autoantibodies that are most frequently directed against PLT glycoproteins IIb/IIIa or Ib/IX/V. Chan et al (25) reported that the most common subclass of anti-IIb/IIIa antibodies in ITP patients was IgG1. Murase et al (22) reported an IgG subclass of a PLT antibody to be potentially IgG4.…”
A 63-year-old woman was referred to Fukushima Red Cross Hospital with an enlargement of the left submandibular gland and subcutaneous bleeding in the chest and legs. A diffuse enlargement of the pancreas was also detected by abdominal computed tomography, and laboratory data showed severe thrombocytopenia. She was diagnosed with IgG4-related disease (IgG4-RD) complicated with autoimmune thrombocytopenia and was treated with methylprednisolone, after which the number of platelets favorably increased. Further investigation for liver dysfunction revealed underlying primary biliary cirrhosis (PBC). We herein report a rare case of IgG4-RD overlapping PBC complicated with autoimmune thrombocytopenia.
“…Patients with ITP have anti-PLT autoantibodies that are most frequently directed against PLT glycoproteins IIb/IIIa or Ib/IX/V. Chan et al (25) reported that the most common subclass of anti-IIb/IIIa antibodies in ITP patients was IgG1. Murase et al (22) reported an IgG subclass of a PLT antibody to be potentially IgG4.…”
A 63-year-old woman was referred to Fukushima Red Cross Hospital with an enlargement of the left submandibular gland and subcutaneous bleeding in the chest and legs. A diffuse enlargement of the pancreas was also detected by abdominal computed tomography, and laboratory data showed severe thrombocytopenia. She was diagnosed with IgG4-related disease (IgG4-RD) complicated with autoimmune thrombocytopenia and was treated with methylprednisolone, after which the number of platelets favorably increased. Further investigation for liver dysfunction revealed underlying primary biliary cirrhosis (PBC). We herein report a rare case of IgG4-RD overlapping PBC complicated with autoimmune thrombocytopenia.
“…An expression level of FcγRII on monocytes was first identified as one of factors associated with H. pylori infection in ITP patients by flow cytometric analysis using a mAb that reacts with both FcγRIIA and FcγRIIB, but this association was later shown to be primarily attributable to inhibitory FcγRIIB based on 2 different assays: quantitative PCR (14,15). It has been shown that anti-GPIIb/IIIa Abs in ITP patients are predominant of the IgG1 subclass (16), which has the highest affinity for FcγRII (13). Thus, FcγRs expressed on macrophages in the RES apparently play a central role in 2 aspects of the pathogenic process: platelet destruction and sustained autoimmune responses to the platelet antigens.…”
Immune thrombocytopenia purpura (ITP) is a bleeding disorder in which platelet-specific autoantibodies cause a loss of platelets. In a subset of patients with ITP and infected with Helicobacter pylori, the number of platelets recovers after eradication of H. pylori. To examine the role of H. pylori infection in the pathogenesis of ITP, the response of 34 ITP patients to treatment with a standard H. pylori eradication regimen, irrespective of whether they were infected with H. pylori, was evaluated. Eradication of H. pylori was achieved in all H. pyloripositive patients, and a significant increase in platelets was observed in 61% of these patients. By contrast, none of the H. pylori-negative patients showed increased platelets. At baseline, monocytes from the H. pylori-positive patients exhibited an enhanced phagocytic capacity and low levels of the inhibitory Fcγ receptor IIB (FcγRIIB). One week after starting the H. pylori eradication regimen, this activated monocyte phenotype was suppressed and improvements in autoimmune and platelet kinetic parameters followed. Modulation of monocyte FcγR balance was also found in association with H. pylori infection in individuals who did not have ITP and in mice. Our findings strongly suggest that the recovery in platelet numbers observed in ITP patients after H. pylori eradication is mediated through a change in FcγR balance toward the inhibitory FcγRIIB.
IntroductionImmune thrombocytopenia purpura (ITP) is an autoimmune disorder caused by increased platelet clearance by anti-platelet autoantibodies (1). In 1998, Gasbarrini et al. reported increase in platelet count in ITP patients infected with Helicobacter pylori after successful eradication of this bacterium (2). Recent accumulating evidence in Italy and Japan indicates that the eradication of H. pylori is effective in increasing the platelet count in nearly half of H. pylori-infected patients with idiopathic ITP (3,4). In addition, a recent report showed that this platelet response lasts for years and cases of relapse are few (5). Based on its efficacy, good safety profile, and low cost, H. pylori eradication therapy for adult ITP is becoming very popular in several countries. Some investigators have suggested that the efficacy of H. pylori eradication in ITP patients may be mediated by H. pylori-independent mechanisms, such as immunomodulatory effects of the drugs used for the regimen (3), but we recently reported its complete lack of efficacy in H. pylori-uninfected ITP patients in a prospective study in which the patients were treated with a standard H. pylori eradication regimen irrespective of their H. pylori infection status (6). This finding clearly indicates that the platelet recovery observed in ITP patients after the eradication regimen results from the disappearance of H. pylori itself.
“…In ITP, an abnormal autoantibody that is usually immunoglobulin G (IgG) with specificity for one or more platelet membrane glycoproteins (GPs) binds to circulating platelet membranes. [10][11][12] In a previous study, it was determined that the PDGF levels are elevated in patients with ITP. 13 In this article, we presented a case that presented both IgAN and ITP, and examine the possible pathophysiological relationship.…”
IgA nephropathy is one of the most common forms of glomerulopathies. It is an immune complex-mediated glomerulonephritis diagnosed by the presence of mesangial IgA deposits that are often associated with mesangial cell proliferation. The IgG, C 3 , IgM, or other immunoglobulin light chains may be co-existed with IgA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.